H. Stewart Parker's most recent trade in Sangamo Therapeutics Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 25,000 | 112,600 (0%) | 0% | 0 | Common Stock | |
| Codexis Inc. | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 40,983 | 143,583 (0%) | 0% | 0 | Common Stock | |
| Codexis Inc. | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 30,120 | 102,600 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 87,600 (0%) | 0% | 0 | Common Stock | |
| Codexis Inc. | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 34,602 | 72,480 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 27,750 | 27,750 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 13,900 | 62,600 (0%) | 0% | 0 | Common Stock | |
| Impel Pharmaceuticals Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,789 | 12,789 | - | - | Stock Option (right to buy) | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 01 Jun 2022 | 5,000 | 48,700 (0%) | 0% | 3.6 | 17,996 | Common Stock |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 12,500 | 43,700 (0%) | 0% | 0 | Common Stock | |
| Impel Pharmaceuticals Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2021 | 11,500 | 11,500 | - | - | Stock Option (right to buy) | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 16,400 | 16,400 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | H. Stewart Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 8,200 | 31,200 (0%) | 0% | 0 | Common Stock |